NCT00491426View on ClinicalTrials.gov

Antimicrobial PK in Infants With Suspected or Confirmed Infection

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

November 30, 2010

Conditions
Infection
Interventions
DRUG

Ampicillin

Drug prescribed per routine medical care.

DRUG

Metronidazole

Drug prescribed per routine medical care.

DRUG

Piperacillin/Tazobactam

Drug prescribed per routine medical care.

DRUG

Acyclovir

Drug prescribed per routine medical care.

DRUG

Amphotericin B

Drug prescribed per routine medical care.

DRUG

Ambisome

Drug prescribed per routine medical care.

DRUG

Anidulafungin

Drug prescribed per routine medical care.

DRUG

Caspofungin

Drug prescribed per routine medical care.

Trial Locations (6)

20010

Children's National Medical Center, Washington D.C.

27705

Duke University Medical Center, Durham

40202

Kosair Children's Hospital, Louisville

48201

Children's Hospital of Michigan, Wayne State University, Detroit

75235

University of Texas Southwestern Medical Center, Dallas

92103

University of California at San Diego, La Jolla

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Pediatric Pharmacology Research Units Network

NETWORK

lead

Duke University

OTHER

NCT00491426 - Antimicrobial PK in Infants With Suspected or Confirmed Infection | Biotech Hunter | Biotech Hunter